An anticancer effect of a new saponin component from Gymnocladus chinensis Baillon through inactivation of nuclear factor-κB

Anti-Cancer Drugs

Volumn 18, Issue 1, 2007, Pages 41-46

  Ma, Yan Xia ^a   Fu, Hong Zheng ^a   Li, Min ^a,b   Sun, Wan ^a   Xu, Bo ^a   Cui, Jing Rong ^a  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Anticancer; Apoptosis; Gymnocladus chinensis Baillon; Nuclear factor B; Triterpenoid saponin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GYMNOCLADUS CHINENSIS EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT; SAPONIN; SULFORHODAMINE B; TRITERPENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HL 60; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; DRUG MECHANISM; FRUIT; GYMNOCLADUS CHINENSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; FRUIT; HELA CELLS; HUMANS; MOLECULAR BIOLOGY; NF-KAPPA B; PLANT EXTRACTS; SAPONINS;

EID: 33845615283     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cad.0000236317.04199.69     Document Type: Article

References (24)

1. Osbourn AE. Saponins in cereals. Phytochemistry 2003; 62:1-4.
2. Zhang HL, Yu XF, Li XX, Pan XR. A study of promotive and fungistatic actions of steroidal saponin by microcalorimetric method. Thermochim Acta 2004; 416:71-74.
3. Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci 2000; 67:1297-1306.
4. 2 production in murine macrophage RAW 264.7 cells. Life Sci 2006; 78: 2336-2342.
5. Jiangsu New Medical College. Dictionary of Chinese materia medica. Shanghai: Shanghai Science and Technology Publisher; 1997. pp. 1430-1431.
6. Konoshima T, Sawada T. Studies on the constituents of leguminous plants. VI. The structure elucidations of monoterpene glycosides from fruits of Gymnocladus chinensis Baillon. Chem Pharm Bull (Tokyo) 1984; 32:2617-2621.
7. Xu MJ, Cui JR, Fu HZ, Proksch P, Lin W, Li M. Embelin derivatives, and their anticancer activity through microtubule disassembly. Planta Med 2005; 71:944-948.
8. Kochlatyi S, Gibbons N, Mattana J. Extracellular matrix oxidation modulates survival, NF-κB translocation, and MAPK activity in mesangial cells. Exp Mol Pathol 2002; 73:191-197.
9. Hsu YL, Kuo PL, Chiang LC, Lin CC. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin in human hepatoma cell lines. Cancer Lett 2004; 213:213-221.
10. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK, et al. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res 2003; 523-524:75-85.
11. Joshi L, Van Eck JM, Mayo K, Di Silvestro R, Blake Nieto ME, Ganapathi T, et al. Metabolomics of plant saponins: bioprospecting triterpene glycoside diversity with respect to mammalian cell targets. Omics 2002; 6:235-246.
12. Sen S, D'Incalci M. Apotosis biochemical events and relevance cancer chemotherapy. FEBS Lett 1992; 307:122-127.
13. Greten FR, Karin M. The IKK/NF-κB activation pathway:a target for prevention and treatment of cancer. Cancer Lett 2004; 206:193-199.
14. Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 2002; 64:883-888.
15. Luo JLi, Kamata H, Karin M. IKK/NF-κB signaling: balancing life and death: a new approach to cancer therapy. J Clin Invest 2005; 115:2625-2632.
16. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-681.
17. Um JH, Kang CD, Lee BG, Kim DW, Chung BS, Kim SH. Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance. Oncogene 2001; 20:6048-6056.
18. Sarkar FH, Li YW. Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 2004; 555:53-64.
19. Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC. Novel mechanism of inhibition of NF-κB DNA-binding activity by diterpenoids isolated from Isodon rubescens. Mol Pharmacol 2005; 68: 286-297.
20. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 2005; 65:6934-6942.
21. Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, et al. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res 2005; 65:9064-9072.
22. Mayo MW, Baldwin AS. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 2000; 1470:55-62.
23. Ozgur K, Huveyda B. Aspirin inhibits TNFα- and IL-1-induced NF-κB activation and sensitizes HeLa cells to apoptosis. Cytokine 2004; 25:229-237.
24. Roussel RR, Barchowsky A. Arsenic inhibits NF-κB-mediated gene transcription by blocking IκBa kinase activity and IκBa phosphorylation and degradation. Arch Biochem Biophys 2000; 377:204-212.